ArticleClinical oral investigations2026
Perioperative loxoprofen sodium is associated with lower pain and anxiety levels in dental implant surgery: a cohort study in China.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo evaluate the effect of a perioperative regimen of 60 mg loxoprofen sodium in Chinese patients who underwent single-tooth implant placement. MATERIALS AND
methods362 patients were allocated to either the loxoprofen group or the control group. Inverse probability of treatment weighting (IPTW) was applied to balance seven baseline covariates. Postoperative infection rate, perceived pain intensity, anxiety levels, and overall patient satisfaction were collected and analyzed.
resultsThe loxoprofen group demonstrated significantly lower VAS pain scores at 30 min preoperative (after premedication), on the evening of implant surgery, and at 24 h after implant surgery (p < 0.001). No significant difference in trait anxiety (T-AI) scores was observed (p = 0.426). State anxiety (S-AI) scores were significantly lower in the loxoprofen group at all three time points (p < 0.001). Postoperative infection rates did not differ significantly (p = 0.266). Patient satisfaction was significantly higher in the loxoprofen group (p < 0.001). Subgroup analyses confirmed beneficial treatment effects across age, sex, BMI, ASA status, smoking status, alcohol consumption, and implant sites.
conclusionsPerioperative administration of loxoprofen sodium was associated with significantly lower pain and state anxiety levels, as well as improved patient satisfaction. The analgesic and anxiolytic effects were most pronounced in the evening of the surgery day. The clinical utility of loxoprofen sodium should be further evaluated in randomized controlled trials. CLINICAL RELEVANCE: A perioperative regimen of loxoprofen sodium significantly reduces pain and state anxiety, and improves patient satisfaction. It may be an effective analgesic in implant dentistry in China, and multicenter long-term randomized controlled studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.